{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:03:42Z","timestamp":1783469022753,"version":"3.55.0"},"reference-count":60,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2016]]},"DOI":"10.5582\/bst.2016.01021","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T22:05:58Z","timestamp":1457561158000},"page":"7-13","source":"Crossref","is-referenced-by-count":39,"title":["Atypical pathogen infection in community-acquired pneumonia"],"prefix":"10.5582","volume":"10","author":[{"given":"Yun","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Emergency, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of Emergency, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001; 163:1730-1754.","DOI":"10.1164\/ajrccm.163.7.at1010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Alvarez-Lerma F, Torres A. Severe community-acquired pneumonia. Curr Opin Crit Care. 2004; 10:369-374.","DOI":"10.1097\/01.ccx.0000140949.05643.34"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA; Community-Acquired Pneumonia Organization (CAPO) Investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007; 175:1086-1093.","DOI":"10.1164\/rccm.200603-350OC"},{"key":"4","unstructured":"4. Wardlaw T, Johansson EW, Hodge M. Pneumonia: The forgotten killer of children. UNICEF, New York, U.S.A., 2006; pp.1-40."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wiemken TL, Peyrani P, Ramirez JA. Global changes in the epidemiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2012; 33:213-219.","DOI":"10.1055\/s-0032-1315633"},{"key":"6","unstructured":"6. Tong CT, Chen HW. Research development on the diagnosis of atypical pathogens in community-acquired pneumonia. Chin J Lung Dis (Electronic Edition). 2014; 7:59-62. (in Chinese)"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Scadding JG. Disseminated Focal Pneumonia. Br Med J. 1937; 2:956-959.","DOI":"10.1136\/bmj.2.4010.956"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fisher HR, Helsby RJ. Three cases of psittacosis with two deaths. Br Med J. 1931; 1:887-888.","DOI":"10.1136\/bmj.1.3672.887"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gulland GL. A note on psittacosisi: With repots of two elated cases. Br Med J. 1924; 2:308-309.","DOI":"10.1136\/bmj.2.3321.308"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Murdoch DR, Chambers ST. Atypical pneumonia--time to breathe new life into a useful term? Lancet Infect Dis. 2009; 9:512-519.","DOI":"10.1016\/S1473-3099(09)70148-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. von Baum H, Welte T, Marre R, Suttorp N, L\u00fcck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009; 9:62-71.","DOI":"10.1186\/1471-2334-9-62"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, YU VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: A prospective, randomized, multicenter trial. Arch Intern Med. 2000; 160:1294-1300.","DOI":"10.1001\/archinte.160.9.1294"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rello J, Bodi M, Mariscal D, Navarro M, Diaz E, Gallego M, Valles J. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest. 2003; 123:174-180.","DOI":"10.1378\/chest.123.1.174"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vergis EN, Akbas E, Yu VL. Legionella as a cause of severe pneumonia. Semin Respir Crit Care Med. 2000; 21:295-304.","DOI":"10.1055\/s-2000-9862"},{"key":"15","unstructured":"15. The infection group of Chinese Thoracic Society. Expert consensus of management of mycoplasma pneumoniae pneumonia in adult. Zhonghua Jie He He Hu Xi Za Zhi. 2010; 33:643-645. (in Chinese)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Musher DM, Thorner AR. Community-acquired pneumonia. N Eng J Med. 2014; 371:1619-1628.","DOI":"10.1056\/NEJMra1312885"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Brown JS. Community-acquired pneumonia. Clin Med (Lond). 2012; 12:538-543.","DOI":"10.7861\/clinmedicine.12-6-538"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004; 17:697-728.","DOI":"10.1128\/CMR.17.4.697-728.2004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003; 9:263-273.","DOI":"10.1046\/j.1469-0691.2003.00590.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kutlin A, Tsumura N, Emre U, Roblin PM, Hammerschlag MR. Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection. Clin Diagn Lab Immunol. 1997; 4:213-216.","DOI":"10.1128\/CDLI.4.2.213-216.1997"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Morozumi M, Nakayama E, Iwata S, Aoki Y, Hasegawa K, Kobayashi R, Chiba N, Tajima T, Ubukata K. Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia byreal-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol. 2006; 44:1440-1446.","DOI":"10.1128\/JCM.44.4.1440-1446.2006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA; Community-Acquired Pneumonia Organization (CAPO) Investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007; 175:1086-1093.","DOI":"10.1164\/rccm.200603-350OC"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cill\u00f3niz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarr\u00fas A, Mensa J, Torres A. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011; 66:340-346.","DOI":"10.1136\/thx.2010.143982"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Capelastegui A, Espa\u00f1a PP, Bilbao A, Gamazo J, Medel F, Salgado J, Gorostiaga I, Lopez de Goicoechea MJ, Gorordo I, Esteban C, Altube L, Quintana JM;Poblational Study of Pneumonia (PSoP) Group. Etiology of community-acquired pneumonia in a population-based study: Link between etiology and patientscharacteristics, process-of-care, clinical evolution and outcomes. Bmc Infectious Diseases. 2012; 12:134-142.","DOI":"10.1186\/1471-2334-12-134"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Luchsinger V, Ruiz M, Zunino E, Mart\u00ednez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Ch\u00e1vez F, Avenda\u00f1o LF. Community-acquired pneumonia in Chile: The clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013; 68:1000-1006.","DOI":"10.1136\/thoraxjnl-2013-203551"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014; 14:335-343.","DOI":"10.1186\/1471-2334-14-335"},{"key":"27","unstructured":"27. van Gageldonk-Lafeber AB, Wever PC, van der Lubben IM, de Jager CP, Meijer A, de Vries MC, Elberse K, van der Sande MA, van der Hoek W. The aetiology of community-acquired pneumonia and implications for patient management. Neth J Med. 2013; 71:418-425."},{"key":"28","unstructured":"28. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010; 12:477-482."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Liu Y, Chen M, Zhao T, et al. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquiredpneumonia in Chinese urban population. BMC Infect Dis. 2009; 9:31-39.","DOI":"10.1186\/1471-2334-9-31"},{"key":"30","unstructured":"30. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J (Engl). 2012; 125:2967-2972."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015; 15:113-118.","DOI":"10.1186\/s12889-015-1422-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratal\u00e0 J. Community-acquired Legionella pneumophila pneumonia:a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore). 2012; 92:51-60.","DOI":"10.1097\/MD.0b013e31827f6104"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Arancibia F, Cortes CP, Vald\u00e9s M, Cerda J, Hern\u00e1ndez A, Soto L, Torres A. Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago, Chile. Chest. 2014; 145:290-296.","DOI":"10.1378\/chest.13-0162"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sopena N, Sabri\u00e0 M, Pedro-Botet ML, Manterola JM, Matas L, Dom\u00ednguez J, Modol JM, Tudela P, Ausina V, Foz M. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis. 1999; 18:852-858.","DOI":"10.1007\/s100960050419"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Liu KT, Yang KY, Lee YC, Perng RP. Risk factor analysis of acute respiratory distress syndrome among hospitalized patients with Chlamydophila pneumoniae pneumonia. J Chin Med Assoc. 2007; 70:318-323.","DOI":"10.1016\/S1726-4901(08)70012-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Wingfield T, Rowell S, Peel A, Puli D, Guleri A, Sharma R. Legionella pneumonia cases over a five-year period: A descriptive, retrospective study of outcomes in a UK district hospital. Clin Med (Lond). 2013; 13:152-159.","DOI":"10.7861\/clinmedicine.13-2-152"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Housset B. Rising to the challenge of resistance: A case study-based discussion. Int J Antimicrob Agents. 2007; 29:S11-S16.","DOI":"10.1016\/S0924-8579(07)70005-5"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 1998; 11:345-349.","DOI":"10.1183\/09031936.98.11020345"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Von Hertzen L, T\u00f6yryl\u00e4 M, Gimishanov A, Bloigu A, Leinonen M, Saikku P, Haahtela T. Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy. 1999; 29:522-528.","DOI":"10.1046\/j.1365-2222.1999.00504.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Koyi H, Brand\u00e9n E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APMIS. 2001; 109:572-580.","DOI":"10.1034\/j.1600-0463.2001.d01-177.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: A case-control study. J Med Microbiol. 2003; 52:721-726.","DOI":"10.1099\/jmm.0.04845-0"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Littman AJ1, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, Vaughan TL. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13:1624-1630.","DOI":"10.1158\/1055-9965.1624.13.10"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Koh WP, Chow VT, Phoon MC, Ramachandran N, Seow A.Lack of association between chronic Chlamydophila pneumoniae infection and lung cancer among nonsmoking Chinese women in Singapore. Int J Cancer. 2005; 114:502-504.","DOI":"10.1002\/ijc.20745"},{"key":"44","unstructured":"44. Yu HM, Tang HY, Wang SF, Shi MJ. Clinical study on impact of Chlamydia pneumoniae infections on pathogenesis of coronary heart disease. Chin J Nosocomi. 2013; 23:2829-2830. (in Chinese)"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Dogra J. Oral azithromycin in extended dosage schedule for chronic, subclinical Chlamydia pneumoniae infection causing coronary artery disease: A probable cure in sight? Results of a controlled preliminary trial. Int J Gen Med. 2012; 5:505-509.","DOI":"10.2147\/IJGM.S31625"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Su X, Chen HL. Chlamydia pneumoniae infection and cerebral infarction risk: A meta-analysis. Int J Stroke. 2014; 9:356-364.","DOI":"10.1111\/ijs.12248"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Huong Ple T, Hien PT, Lan NT, Binh TQ, Tuan DM, Anh DD. First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1-15 years. BMC Public Health. 2014; 14:1304-1311.","DOI":"10.1186\/1471-2458-14-1304"},{"key":"48","unstructured":"48. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, Nakayama E, Sunakawa K, Ubukata K; Acute Respiratory Diseases Study Group. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. 2008; 52:348-350."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Dumke R, von Baum H, L\u00fcck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010; 16:613-616.","DOI":"10.1111\/j.1469-0691.2009.02968.x"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Peuchant O, M\u00e9nard A, Renaudin H, Morozumi M, Ubukata K, B\u00e9b\u00e9ar CM, Pereyre S. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009; 64:52-58.","DOI":"10.1093\/jac\/dkp160"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010; 51:189-194.","DOI":"10.1086\/653535"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: Its role in respiratory infection. J Antimicrob Chemother. 2013; 68:506-511.","DOI":"10.1093\/jac\/dks457"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2014; 58:1034-1038.","DOI":"10.1128\/AAC.01806-13"},{"key":"54","unstructured":"54. Chinese Thoracic Society. Guildelines for the management of community-acquired pneumonia in China. Zhonghua Jie He He Hu Xi Za Zhi. 2006; 29:651-655. (in Chinese)"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44:S27-S72.","DOI":"10.1086\/511159"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Verheij TJ; European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005; 26:1138-1180.","DOI":"10.1183\/09031936.05.00055705"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: An update and new recommendations. Intern Med. 2006; 45:419-428.","DOI":"10.2169\/internalmedicine.45.1691"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community-acquired pneumonia: Systematic review of randomized controlled trials. Arch Intern Med. 2005; 165:1992-2000.","DOI":"10.1001\/archinte.165.17.1992"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Ye X, Ma J, Hu B, Gao X, He L, Shen W, Weng L, Cai L, Huang Y, Hu Z, Xu J, Zhao L, Huang M, Cui X, Tu C. Improvement of Clinical and Economic Outcomes with an Empiric antibiotic therapy covering Atypical Pathogens for Community-acquired Pneumonia patients:a Multi-center Cohort Study. Int J Infect Dis. 2015; 144:102-107.","DOI":"10.1016\/j.ijid.2015.03.012"},{"key":"60","unstructured":"60. Yin YD, Cao B, Wang H, Wang RT, Liu YM, Gao Y, Qu JX, Han GJ, Liu YN. Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China. Zhonghua Jie He He Hu Xi Za Zhi. 2013; 36:954-958. (in Chinese)"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/10\/1\/10_2016.01021\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T20:53:12Z","timestamp":1655239992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/10\/1\/10_2016.01021\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2016.01021","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}